Physician profile
Charmi Patel
NPI 1003466988
$1,479.84
in general payments reported to CMS, 2019-2025
25 companies · $892 in 2025
The $892 reported for 2025 was more than what 85% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $79.00 · 2024: $509 · 2025: $892.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,480.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,479.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $178.61 | 2025 | |
| Medtronic, INC. | $172.84 | 2025 | Interstim |
| Sumitomo Pharma America, INC. | $107.88 | 2024-2025 | Gemtesa, Orgovyx |
| Astrazeneca Pharmaceuticals LP | $103.91 | 2023-2024 | Onglyza, Breztri, Farxiga |
| Myriad Genetic Laboratories, INC. | $95.62 | 2024-2025 | Prolaris |
| Laborie Medical Technologies Corp. | $70.41 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter, Endosheath Technology |
| Coloplast Corp | $68.13 | 2023-2024 | Speedicath |
| Astellas Pharma US INC | $67.58 | 2025 | Xtandi, Veozah |
| Blue Earth Diagnostics | $57.61 | 2025 | Posluma |
| Procept Biorobotics Corporation | $55.68 | 2024-2025 | Aquabeam System |
| Abiomed | $53.67 | 2024 | Impella |
| Urogen Pharma, INC. | $52.36 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $48.78 | 2025 | Personal Catheter Intermittent Catheter, Purewick Female External Catheter |
| Progenics Pharmaceuticals, INC. | $46.32 | 2024 | |
| Janssen Scientific Affairs, LLC | $42.15 | 2023-2024 | Akeega, Pipeline, Erleada |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $39.47 | 2025 | Journavx |
| Abbvie INC. | $36.48 | 2024-2025 | |
| Janssen Biotech, INC. | $35.92 | 2025 | Erleada |
| Ambu INC. | $34.82 | 2024 | |
| Bluewind Medical | $21.77 | 2025 | Revi |
| Dendreon Pharmaceuticals LLC | $20.22 | 2025 | Provenge |
| Axogen | $19.91 | 2025 | |
| Boston Scientific Corporation | $17.25 | 2024 | Rezum Generator |
| Sanofi Pasteur INC. | $16.80 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.65 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charmi Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.